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Systematic Review of Randomized Controlled Trials of
Patch Angioplasty Versus Primary Closure and Different
Types of Patch Materials During Carotid Endarterectomy
Kittipan Rerkasem1, Peter M. Rothwell2. 1Department of
Surgery, Chiang Mai University, Chiang Mai, Thailand;
2University of Oxford, Oxford, United Kingdom
Objectives: Patch angioplasty during carotid endarterec-
tomy (CEA)may reduce the risk for perioperative or late carotid
artery recurrent stenosis and subsequent ischemic stroke. We
performed a systematic review of randomized controlled trials to
assess the effect of routine or selective carotid patch angioplasty
compared with CEA with primary closure, and the effect of
different materials used for carotid patch angioplasty.
Methods: Randomized trials during 1966-2009 were
included if they compared carotid patch angioplasty with
primary closure in any patients undergoing CEA or use of
one type of carotid patch with another.
Results: Twenty-three eligible randomized trials were
identified. Ten trials involving 2157 operations compared
primary closure with routine patch closure, and thirteen
trials with 2083 operations compared different patch ma-
terials. Patch angioplasty was associated with a reduction in
risk for ipsilateral stroke during the perioperative period
(p 0.001), and long-term follow-up (p 0.001). Patch-
ing was also associated with reduced risk for perioperative
arterial occlusion (P .0001) and decreased recurrent ste-
nosis during long-term follow-up (p 0.001). Seven trials
that compared between vein and synthetic patches showed
that apart from psudoanaeurysmal formation, there were
no significant different in the outcome between vein patch
and synthetic materials in either the short- or long-term.
There were significantly fewer pseudoaneurysms associated
with synthetic patches than vein patches (p  0.005).
Conclusions: Carotid patch angioplasty decreases the
risk for both ipsilateral stroke in both perioperative and
long-term risk. More data are required to establish differ-
ences between various patch materials.
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Retrograde Supra-aortic Stent Placement Combined
With Open Carotid or Subclavian Artery Revascular-
ization
Nitin Garg1, Gustavo S. Oderich1, Audra A. Duncan1,
Joseph J. Ricotta1, Gautam Agarwal2, Manju Kalra1,
Thomas C. Bower1, Peter Gloviczki1. 1Vascular And En-
dovascular Surgery, Mayo Clinic, Rochester, MN; 2Medi-
cal College of Georgia, Augusta, GA
Objectives: To evaluate the outcomes of retrograde
supra-aortic stent placement (RSAS) combined with open
carotid or subclavian artery revascularization.Methods: We retrospectively reviewed all patients who
had open carotid or subclavian artery revascularization
combined with RSAS of the common carotid (CCA) or
innominate arteries (IA) between 1995 and 2008. Isolated
percutaneous or retrograde stent placements via carotid
artery cutdown were excluded.
Results: 11 patients (2 male and 9 female, mean age 66
years) underwent RSAS of 10 CCA and 1 IA lesions combined
withopen revascularization.Fivepatientshad symptomatic and3
had asymptomatic high-grade carotid stenoses or upper extrem-
ity claudication equivalent. Open revascularization included ca-
rotid endarterectomy in 6 patients, carotid-subclavian bypass in
3, and carotid-carotid bypass in 2. There were no early compli-
cations and the average hospital stay was 3 1 days. All symp-
tomatic patients improved and therewere no recurrent ipsilateral
neurological or upper extremity symptoms. Over a mean fol-
low-up of 19 months, one patient developed CCA in-stent
restenosis which was treated with subclavian-carotid bypass and
later had a contralateral stroke. There were no restenoses or
reinterventions related to open revascularization.
Conclusions: Retrograde common carotid or innominate
artery stentplacement is a safe andeffective treatment for selected
patients with severe supra-aortic inflow disease who require con-
comitant open carotid or subclavian artery reconstructions.
Author Disclosures: G. Agarwal: Nothing to disclose; T. C.
Bower: Nothing to disclose; A. A. Duncan: Nothing to dis-
close; N. Garg: Nothing to disclose; P. Gloviczki: Nothing to
disclose;M.Kalra:Nothing todisclose;G.S.Oderich:Nothing
to disclose; J. J. Ricotta: Nothing to disclose.
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Aspirin vs Aspirin/Plavix in the Prevention of Stroke:
A Meta-analysis
Eleftherios S. Xenos, Shane O’Keeffe, David Minion, Ehab
Sorial, Eric Endean. University of Kentucky, VA Medical
Center, Lexington, KY
Objectives: Antiplatelet therapy reduces the rate of
cardiovascular events in patients with atherosclerotic vascu-
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effect of the combination of ASA/plavix compared with
ASA alone in the prevention of stoke in patients with
symptomatic cardiovascular disease.
Methods: A systematic search of randomized con-
trolled trials reporting treatment of cardiovascular disease
with antiplatelet agents was performed. Statistical analysis
was performed using the commercially available software
CMAVersion 2 (Biostat Inc, Englewood NJ). The random
effects model was used. All statistical testing was two-tailed.
Results: Four randomized controlled trials from 2001
to 2008 were included, these reported on 31445 patients,
15380 were treated with ASA and 16065 with ASA/plavix.
There was no difference between the age/gender distribu-
tion among the two groups. The prevalence of diabetes,
hypertension, and history of smoking was similar (P0.05
for all comparisons). Range of treatment/follow-up period
was 9-27.6 months. The risk of stroke was lower for the
patients receiving aspirin and plavix (image 1, p  0.001).
There was a slight difference in risk of bleeding requiring
transfusion that was in favor of the ASA group (p 0.042).
Conclusions: Our meta-analysis indicates that the
combination of aspirin and plavix may be superior to aspirin
alone for prevention of stroke in patients with symptomatic
cardiovascular disease. There does appear to be slight in-
crease in risk of nonfatal bleeding with this combination.
Author Disclosures: E. Endean: Nothing to disclose; D.
Minion: WL Gore, Speaker’s bureau; S. O’Keeffe: Noth-
ing to disclose;E. Sorial: Nothing to disclose;E. S. Xenos:
Nothing to disclose.
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Hybrid Procedures for the One-stage Treatment of
Multi-focal Ipsilateral Internal Carotid and Proximal
Common Carotid/Innominate Artery Lesions
Christos Karathanos1, Georgios Antoniou1, Konstantinos
Stamoulis2, Katerina Drakou1, Georgios Vretzakis2, Atha-
nasios Giannoukas1. 1Dept. of Vascular Surgery, University
Hospital of Larissa, Larissa, Greece; 2Dept. of Anesthesiol-
ogy, University Hospital of Larissa, Larissa, Greece
Objectives: To report our experience with one-stage
hybrid treatment of ipsilateral proximal common carotid(CCA)/innominate and internal carotid artery (ICA) sig-
nificant stenosis.
Methods: Our vascular service offers both carotid
endarterectomy (CEA) and stenting (CAS) on specific
indications. Over the last two years (2008 - 2009) 96
carotid procedures were performed in 92 patients; 67
CEA (32 symptomatic) and 29 CAS (12 symptomatic).
Two patients with symptomatic and one with asymptom-
atic high grade (70%) ipsilateral internal and proximal
CCA stenosis were treated in one-stage with CEA and
retrograde CAS of the CCA. CEA was always performed
first and before completion of patch closure retrograde
CCA stenting was performed. ICA was clamped during
stenting. In 2 patients CEA was carried out with shunt.
All patients were under continuous electroencephalo-
graphic (EEC) monitoring.
Results: Hybrid carotid procedures for ipsilateral ca-
rotid disease were performed in three patients out of 92
(3.2%). All procedures were successfully completed. No
EEC changes were recorded. Completion angiography and
imaging one month postoperatively showed optimal stent
placement and good patency. No 30-day neurological mor-
bidity or mortality was recorded. In the one-year follow-up
all patients remained asymptomatic, recurrent ICA stenosis
50-69% in one patient and progression of a preexisting
moderate (30-49%) mid-CCA stenosis to a significant one
(70%) in another patient were detected.
Conclusions: Our experience and the literature sup-
port that one-stage CEA and retrograde CCA/innominate
artery stenting is a safe and effective procedure in those few
patients with extensive atherosclerosis of the extracranial
cerebrovascular arteries.
Author Disclosures: G. Antoniou: Nothing to disclose;
K. Drakou: Nothing to disclose;A. Giannoukas: Nothing
to disclose; C. Karathanos: Nothing to disclose; K. Sta-
moulis: Nothing to disclose; G. Vretzakis: Nothing to
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Proximal Vertebral Artery Disease: Surgical Recon-
struction or Stenting?
Shipra Arya1, Iraklis Pipinos2, Eugene A. Waltke3, Scott P.
Wattenhofer3, Bernard T. Baxter2. 1Creighton University
Medical Center, Omaha, NE; 2University of Nebraska
Medical Center, Omaha, NE; 3Methodist Hospital,
Omaha, NE
Objectives: The origin of the vertebral artery (VA) is
a common site of atherosclerosis that may lead to poste-
rior circulation infarcts. Surgery was once the mainstay of
therapy for proximal VA disease but contemporary stud-
ies suggest interventional approaches are nowmore com-
mon. We present a case series of VA transposition in 5
patients and a systematic review of literature comparing
angioplasty/stent with surgical revascularization.
